Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer

被引：10
|
作者：
Fagotti, Anna [1 ,2 ]
Scambia, Giovanni [1 ,2 ]
机构：
[1] Fdn Policlin Univ Agostino Gemelli, IRCCS, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 12期
关键词：
OVARIAN-CANCER;
D O I：
10.1016/S1470-2045(18)30625-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1558 / 1560
页数：3
相关论文
共 50 条
  • [41] Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Bian, Ce
    Yao, Kui
    Li, Li
    Yi, Tao
    Zhao, Xia
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (01) : 163 - 168
  • [42] Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer
    Cowan, Renee A.
    Chi, Dennis S.
    Fagotti, Anna
    Scambia, Giovanni
    ONCOLOGY-NEW YORK, 2017, 31 (06): : 453 - +
  • [43] Primary debulking surgery versus neoadjuvant chemotherapy in elderly patients with epithelial ovarian cancer
    Xu, Z.
    Justiniano, C. F.
    Fleming, F. J.
    Boscoe, F. P.
    Schymura, M. J.
    Rubinsak, L. A.
    Morrow, G.
    Minasian, L.
    Temkin, S. M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 78 - 78
  • [44] NEOADJUVANT CHEMOTHERAPY OR FIRST LINE DEBULKING SURGERY IN ADVANCED OVARIAN CANCERS
    Chekman, Chemseddine
    Gouaref, Fatiha
    Bentabak, Kamel
    Hadjarrab, Fatiha
    Bouzid, Kamel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A127 - A127
  • [45] Neo-adjuvant Chemotherapy Followed by Interval Debulking Surgery Versus Upfront Surgery Followed by Chemotherapy in Advanced Epithelial Ovarian Carcinoma
    Meleis M.H.
    El-Agwany A.S.
    Indian Journal of Gynecologic Oncology, 2016, 14 (1)
  • [46] Management of Advanced Staged Ovarian Cancer in a National Cancer Center: Comparison of the Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy
    Kovacevic, Nina
    Skof, Erik
    Cilensek, Ines
    Merlo, Sebastjan
    CURRENT WOMENS HEALTH REVIEWS, 2021, 17 (03) : 267 - 273
  • [47] A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy
    May, Taymaa
    Comeau, Robyn
    Sun, Ping
    Kotsopoulos, Joanne
    Narod, Steven A.
    Rosen, Barry
    Ghatage, Prafull
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (04) : 668 - 674
  • [48] Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals
    Kobal, Borut
    Noventa, Marco
    Cvjeticanin, Branko
    Barbic, Matija
    Meglic, Leon
    Herzog, Marusa
    Bordi, Giulia
    Vitagliano, Amerigo
    Saccardi, Carlo
    Skof, Erik
    RADIOLOGY AND ONCOLOGY, 2018, 52 (03) : 307 - 319
  • [49] The impact of secondary cytoreductive surgery in platinum sensitive recurrent ovarian cancer treated with upfront neoadjuvant chemotherapy and interval debulking surgery
    Bizzarri, Nicolo
    Marchetti, Claudia
    Conte, Carmine
    Loverro, Matteo
    Giudice, Maria Teresa
    Quagliozzi, Lorena
    Distefano, Mariagrazia
    Chiantera, Vito
    Scambia, Giovanni
    Fagotti, Anna
    GYNECOLOGIC ONCOLOGY, 2022, 165 (03) : 453 - 458
  • [50] Interval from neoadjuvant chemotherapy to interval debulking surgery in advanced ovarian cancer: Is this a prognostic indicator?
    Hariprasad, R.
    Kumar, L.
    Mookerjee, A.
    Radhakrishnan, V.
    Kumar, S.
    Mathur, S.
    Thulkar, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345